Newbury Pharmaceuticals

Lund, Sweden

Newbury Pharmaceuticals is building a pipeline of proprietary and licensed products to become a leading generic pharma company.

$1.8M raised

Mar 2024

Post-IPO Equity

Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Newbury Pharmaceuticals

How much funding has Newbury Pharmaceuticals raised?

Newbury Pharmaceuticals has raised $1.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2024.

Where is Newbury Pharmaceuticals headquartered?

Newbury Pharmaceuticals is headquartered in Lund, Sweden.

What does Newbury Pharmaceuticals do?

Newbury Pharmaceuticals is building a pipeline of proprietary and licensed products to become a leading generic pharma company.

What stage is Newbury Pharmaceuticals at?

Newbury Pharmaceuticals is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 4, 2024.

MLA

"Newbury Pharmaceuticals — Funding & Investors." VCBacked, March 4, 2024, https://www.vcbacked.co/company/newbury-pharmaceuticals. Accessed July 3, 2026.

APA

VCBacked. (2024). Newbury Pharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/newbury-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Newbury Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/newbury-pharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 4, 2024.